This medical video focuses on the vaccine against Lymphoma.
Read the full transcript »
Jennifer Matthews: Two years ago, Tom Steeves complained to his doctor of swelling in his neck. Tom Steeves: I said, I have never felt these before. This is not normal. Jennifer Matthews: Tom had a slow-growing but stubborn form of non-Hodgkin's lymphoma, cancer of the Lymph System that almost always comes back, even after chemotherapy. Dr. Craig Nichols: Eventually, most of these patients ultimately develop resistant disease and die of their lymphoma. Tom Steeves: That's the unfortunate thing about non-Hodgkin's lymphoma B-cells, is that the patient just has to wait and see what happens. Jennifer Matthews: Tom didn't want to wait, so he enrolled in a clinical trial to test a tailor-made vaccine. Dr. Craig Nichols: And this really is the ultimate targeted-therapy. Jennifer Matthews: The vaccine is made from a unique protein pattern from the patient's own tumor. It teaches the immune system to recognize cancer cells and kill them. Craig Nichols: There are certainly patients who have been vaccinated who have yet to have their cancer return, and whether those patients are cured, or simply are having very long remissions, we don't know yet. Jennifer Matthews: Doctor Nichols says some patients in the very first lymphoma vaccine trials have been cancer-free for ten years. Tom Steeves: I just love these flowers. Jennifer Matthews: Tom hopes to live twice that long which would put him into his 90s. This is Jennifer Matthews reporting.